Market revenue in 2023 | USD 342.2 million |
Market revenue in 2030 | USD 334.1 million |
Growth rate | -0.3% (CAGR from 2023 to 2030) |
Largest segment | Immunoturbidimetric assay |
Fastest growing segment | Immunoturbidimetric Assay |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunoturbidimetric Assay, Chemiluminescence Immunoassay, Other Assay Types, ELISA |
Key market players worldwide | Thermo Fisher Scientific Inc, Roche Holding AG ADR, Danaher Corp, Quest Diagnostics Inc, Siemens Healthineers AG ADR, Abbott Laboratories, Merck KGaA, Zoetis Inc Class A, QuidelOrtho Corp, Horiba Ltd, Getein Biotech, Boditech Med, Randox, Aidian |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to c-reactive protein testing market will help companies and investors design strategic landscapes.
Immunoturbidimetric assay was the largest segment with a revenue share of 48.48% in 2023. Horizon Databook has segmented the Germany c-reactive protein testing market based on immunoturbidimetric assay, chemiluminescence immunoassay, other assay types, elisa covering the revenue growth of each sub-segment from 2018 to 2030.
Germany accounted for the highest share in the European market in 2020 and is expected to grow further over the forecast period. This can be attributed to factors such as ongoing investigations, favorable regulatory policies, and rising incidence of various inflammatory disorders.
Moreover, increase in support by various organizations such as German Centre for Cardiovascular Research (DZHK) and WHO for development of novel CRP testing devices is expected to boost the market growth.
In addition, various investigations in the field of cancer & cardiovascular disorders are also expected to drive further progressions in the CRP testing market. According to Robert Koch Institute in Germany, each year, 480,000 people are diagnosed with cancer, which increases the need for rapid diagnostics.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany c-reactive protein testing market , including forecasts for subscribers. This country databook contains high-level insights into Germany c-reactive protein testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account